SPY323.50+0.86 0.27%
DIA268.10+0.52 0.19%
IXIC10,672.27+39.28 0.37%

Bank of America Initiates Coverage On Checkmate Pharmaceuticals with Neutral Rating, Announces Price Target of $19

Bank of America initiates coverage on Checkmate Pharmaceuticals (NASDAQ:CMPI) with a Neutral rating and announces Price Target of $19.

 · 
Bank of America initiates coverage on Checkmate Pharmaceuticals (NASDAQ:CMPI) with a Neutral rating and announces Price Target of $19.